abrdn Healthcare Investors (NYSE:HQH – Get Free Report) saw a large increase in short interest in the month of April. As of April 30th, there was short interest totaling 142,452 shares, an increase of 190.1% from the April 15th total of 49,111 shares. Approximately 0.3% of the company’s stock are sold short. Based on an average daily trading volume, of 123,341 shares, the short-interest ratio is presently 1.2 days.
Institutional Trading of abrdn Healthcare Investors
Large investors have recently made changes to their positions in the company. Bollard Group LLC acquired a new stake in shares of abrdn Healthcare Investors in the 1st quarter valued at about $25,000. Eastern Bank acquired a new position in abrdn Healthcare Investors during the 3rd quarter valued at about $30,000. Guerra Advisors Inc acquired a new position in abrdn Healthcare Investors during the 3rd quarter valued at about $39,000. Geneos Wealth Management Inc. boosted its stake in abrdn Healthcare Investors by 9,232.3% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock valued at $45,000 after purchasing an additional 2,862 shares during the last quarter. Finally, Flagship Harbor Advisors LLC acquired a new position in abrdn Healthcare Investors during the 4th quarter valued at about $48,000. 32.60% of the stock is currently owned by institutional investors and hedge funds.
abrdn Healthcare Investors Stock Performance
Shares of HQH opened at $20.25 on Friday. The stock has a 50-day moving average of $18.91 and a 200-day moving average of $19.04. abrdn Healthcare Investors has a one year low of $15.09 and a one year high of $20.46.
abrdn Healthcare Investors Announces Dividend
About abrdn Healthcare Investors
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Read More
- Five stocks we like better than abrdn Healthcare Investors
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
